Increased serum levels of inflammatory mediators and low frequency of regulatory T cells in the peripheral blood of Preeclamptic Mexican Women

BioMed Research International

Volumn 2014, Issue , 2014, Pages

  Moreno Eutimio, Mario Adan ^a   Tovar Rodríguez, José María ^a   Vargas Avila, Karina ^a   Nieto Velázquez, Nayeli Goreti ^a   Frías De León, María Guadalupe ^a   Sierra Martinez, Mónica ^a   Acosta Altamirano, Gustavo ^a  

^a HOSPITAL JUÁREZ DE MÉXICO   (Mexico)

Author keywords

[No Author keywords available]

Indexed keywords

CXCL9 CHEMOKINE; GAMMA INTERFERON INDUCIBLE PROTEIN 10; INTERLEUKIN 10; INTERLEUKIN 1BETA; INTERLEUKIN 6; INTERLEUKIN 8; MONOCYTE CHEMOTACTIC PROTEIN 1; TRANSCRIPTION FACTOR FOXP3; TUMOR NECROSIS FACTOR ALPHA; CCL2 PROTEIN, HUMAN; CXCL10 PROTEIN, HUMAN; CXCL9 PROTEIN, HUMAN; FORKHEAD TRANSCRIPTION FACTOR; FOXP3 PROTEIN, HUMAN; IL2RA PROTEIN, HUMAN; INTERLEUKIN 2 RECEPTOR ALPHA;

ADULT; ARTICLE; BLOOD ANALYSIS; CD4+ CD25+ T LYMPHOCYTE; CONTROLLED STUDY; DISEASE SEVERITY; FEMALE; FLOW CYTOMETRY; HUMAN; INFLAMMATION; MAJOR CLINICAL STUDY; MEDIATOR RELEASE; MEXICAN; PREECLAMPSIA; REGULATORY T LYMPHOCYTE; YOUNG ADULT; BLOOD; CD4+ T LYMPHOCYTE; IMMUNOLOGY; MEXICO; PATHOLOGY; PREGNANCY;

ADULT; CD4-POSITIVE T-LYMPHOCYTES; CHEMOKINE CCL2; CHEMOKINE CXCL10; CHEMOKINE CXCL9; FEMALE; FLOW CYTOMETRY; FORKHEAD TRANSCRIPTION FACTORS; HUMANS; INFLAMMATION; INTERLEUKIN-2 RECEPTOR ALPHA SUBUNIT; INTERLEUKIN-8; MEXICO; PRE-ECLAMPSIA; PREGNANCY; T-LYMPHOCYTES, REGULATORY; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84919722845     PISSN: 23146133     EISSN: 23146141     Source Type: Journal    
DOI: 10.1155/2014/413249     Document Type: Article

References (40)

1. M. Noris, N. Perico, and G. Remuzzi, "Mechanisms of disease: pre-eclampsia," Nature clinical practice. Nephrology, vol. 1, no. 2, pp. 98-114, 2005
2. E. N. Sánchez-Rodríguez, S. Nava-Salazar, C. Morán, J. F. Romero-Arauz, and M. A. Cerbón-Cervantes, "Thetwo leading hypothesis regarding the molecular mechanisms and etiology of preeclampsia, and the Mexican experience in the world context," Revista de Investigacion Clinica, vol. 62, no. 3, pp. 252-260, 2010
3. O. Basso, S. Rasmussen, C. R. Weinberg, A. J. Wilcox, L. M. Irgens, and R. Skjaerven, "Trends in fetal and infant survival following preeclampsia," Journal of the AmericanMedical Association, vol. 296, no. 11, pp. 1357-1362, 2006
4. A. Molvarec, Á. Vér, A. Fekete et al., "Association between estrogen receptor (ESR1) gene polymorphisms and severe preeclampsia," Hypertension Research, vol. 30, no. 3, pp. 205-211, 2007
5. A. Molvarec, Á. Jermendy, B. Nagy et al., "Association between tumor necrosis factor (TNF) G-308A gene polymorphism and preeclampsia complicated by severe fetal growth restriction," Clinica Chimica Acta, vol. 392, no. 1-2, pp. 52-57, 2008
6. K. Rosta, A. Molvarec, A. Enzsoly et al., "Association of extracellular superoxide dismutase (SOD3) Ala40Thr gene polymorphism with pre-eclampsia complicated by severe fetal growth restriction," European Journal of Obstetrics Gynecology and Reproductive Biology, vol. 142, no. 2, pp. 134-138, 2009
7. N. C. Serrano, "Immunology and genetic of preeclampsia," Clinical and Developmental Immunology, vol. 13, no. 2-4, pp. 197-201, 2006
8. A. Erlebacher, "Immunology of the maternal-fetal interface," Annual Review of Immunology, vol. 31, pp. 387-411, 2013
9. D. G. Harrison, T. J. Guzik, H. E. Lob et al., "Inflammation, immunity, and hypertension," Hypertension, vol. 57, no. 2, pp. 132-140, 2011
10. N. Ohkura, Y. Kitagawa, and S. Sakaguchi, " Development and maintenance of regulatory T cells," Immunity, vol. 38, no. 3, pp. 414-423, 2013
11. J. D. Fontenot, M. A. Gavin, and A. Y. Rudensky, "Foxp3 programs the development and function of CD4+CD25+ regulatory T cells," Nature Immunology, vol. 4, no. 4, pp. 330-336, 2003
12. V. R. Aluvihare, M. Kallikourdis, and A. G. Betz, "Regulatory T cells mediate maternal tolerance to the fetus," Nature Immunology, vol. 5, no. 3, pp. 266-271, 2004
13. S. Verlohren, D. N. Muller, F. C. Luft, and R. Dechend, "Immunology in hypertension, preeclampsia, and target-organ damage," Hypertension, vol. 54, no. 3, pp. 439-443, 2009
14. A. Zlotnik and O. Yoshie, "The Chemokine Superfamily Revisited," Immunity, vol. 36, no. 5, pp. 705-712, 2012
15. F. Azizieh, R. Raghupathy, and M. Makhseed, "Maternal cytokine production patterns in women with pre-eclampsia," American Journal of Reproductive Immunology, vol. 54,no. 1, pp. 30-37, 2005
16. A. Szarka, J. Rigo Jr., L. Lazar, G. Beko, and A. Molvarec, "Circulating cytokines, chemokines and adhesion molecules in normal pregnancy and preeclampsia determined by multiplex suspension array," BMC Immunology, vol. 11, article 59, 2010
17. A. Molvarec, A. Szarka, S. Walentin et al., "Serum leptin levels in relation to circulating cytokines, chemokines, adhesion molecules and angiogenic factors in normal pregnancy and preeclampsia," Reproductive Biology and Endocrinology, vol. 9, article 124, 2011
18. S. Saito, Y. Sasaki, and M. Sakai, "CD4+CD25high regulatory T cells in human pregnancy," Journal of Reproductive Immunology, vol. 65, no. 2, pp. 111-120, 2005
19. A. Steinborn, G. M. Haensch, K. Mahnke et al., "Distinct subsets of regulatory T cells during pregnancy: Is the imbalance of these subsets involved in the pathogenesis of preeclampsia" Clinical Immunology, vol. 129, no. 3, pp. 401-412, 2008
20. J. R. Prins, H. M. Boelens, J. Heimweg et al., "Preeclampsia is associated with lower percentages of regulatory T cells in maternal blood," Hypertension in Pregnancy, vol. 28, no. 3, pp. 300-311, 2009
21. Y. Sasaki, D. Darmochwal-Kolarz, D. Suzuki et al., "Proportion of peripheral blood and decidual CD4+ CD25? regulatory T cells in pre-eclampsia," Clinical and Experimental Immunology, vol. 149, no. 1, pp. 139-145, 2007
22. D. Darmochwal-Kolarz, S. Saito, J. Rolinski et al., "Activated T lymphocytes in pre-eclampsia," The American Journal of Reproductive Immunology, vol. 58, no. 1, pp. 39-45, 2007
23. G. Toldi, J. Rigo Jr., B. Stenczer, B. Vasarhelyi, and A. Molvarec, "Increased prevalence of IL-17-producing peripheral blood lymphocytes in pre-eclampsia," The American Journal of Reproductive Immunology, vol. 66, no. 3, pp. 223-229, 2011
24. G. Toldi, S. Saito, T. Shima et al., "The frequency of peripheral blood CD4+ CD25high FoxP3+ and CD4+ CD25-FoxP3+ regulatory T cells in normal pregnancy and pre-eclampsia," The American Journal of Reproductive Immunology, vol. 68,no. 2, pp. 175-180, 2012
25. D. Hu, Y. Chen, W. Zhang, H. Wang, Z. Wang, and M. Dong, "Alteration of peripheral CD4+CD25+ regulatory T lymphocytes in pregnancy and pre-eclampsia," Acta Obstetricia et Gynecologica Scandinavica, vol. 87, no. 2, pp. 190-194, 2008
26. S. Paeschke, F. Chen, N. Horn et al., "Pre-eclampsia is not associated with changes in the levels of regulatory T cells in peripheral blood," The American Journal of Reproductive Immunology, vol. 54, no. 6, pp. 384-389, 2005
27. M. Knuist, G. J. Bonsel, H. A. Zondervan, and P. E. Treffers, "Risk factors for preeclampsia in nulliparous women in distinct ethnic groups: a prospective cohort study," Obstetrics and Gynecology, vol. 92, no. 2, pp. 174-178, 1998
28. J. Gong, D. A. Savitz, C. R. Stein, and S. M. Engel, "Maternal ethnicity and pre-eclampsia in New York City, 1995-2003," Paediatric and Perinatal Epidemiology, vol. 26, no. 1, pp. 45-52, 2012
29. M. A. Brown, M. D. Lindheimer, M. de Swiet, A. van Assche, and J. M. Moutquin, "The classification and diagnosis of the hypertensive disorders of pregnancy: statement from the International Society for the Study of Hypertension in Pregnancy (ISSHP)," Hypertension in Pregnancy, vol. 20, no. 1, pp. 9-14, 2001
30. A. Molvarec, A. Szarka, S. Walentin, E. Szucs, B. Nagy, and J. Rigó, "Circulating angiogenic factors determined by electrochemiluminescence immunoassay in relation to the clinical features and laboratory parameters in women with pre-eclampsia," Hypertension Research, vol. 33, no. 9, pp. 892-898, 2010
31. D. A. Somerset, Y. Zheng, M. D. Kilby, D. M. Sansom, and M. T. Drayson, "Normal human pregnancy is associated with an elevation in the immune suppressive CD25 + CD4 + regulatory T-cell subset," Immunology, vol. 112, no. 1, pp. 38-43, 2004
32. A. Erlebacher, "Mechanisms of T cell tolerance towards the allogeneic fetus," Nature Reviews Immunology, vol. 13, no. 1, pp. 23-33, 2013
33. U. G. Svendsen, "Evidence for an initial, thymus independent and a chronic, thymus dependent phase of DOCA and salt hypertension in mice," Acta Pathologica et Microbiologica Scandinavica-Section A Pathology, vol. 84, no. 6, pp. 523-528, 1976
34. B. LaMarca, J. Speed, L. F. Ray et al., "Hypertension in response to IL-6 during pregnancy: role of AT1-receptor activation," International Journal of Interferon, Cytokine and Mediator Research, vol. 3, no. 1, pp. 65-70, 2011
35. E. S. Purcell and V. H. Gattone II, "Immune system of the spontaneously hypertensive rat I. Sympathetic innervation," Experimental Neurology, vol. 117, no. 1, pp. 44-50, 1992
36. C. J. Lockwood, C.-F. Yen, M. Basar et al., "Preeclampsia-related inflammatory cytokines regulate interleukin-6 expression in human decidual cells," American Journal of Pathology, vol. 172, no. 6, pp. 1571-1579, 2008
37. Y. Wang, J. Baier, C. D. Adair et al., "Interleukin-8 stimulates placental prostacyclin production in preeclampsia," The American Journal of Reproductive Immunology, vol. 42, no. 6, pp. 375-380, 1999
38. M. Tosun, H. Celik, B. Avci, E. Yavuz, T. Alper, and E. Malatyalio glu, "Maternal and umbilical serum levels of interleukin-6, interleukin-8, and tumor necrosis factor in normal pregnancies and in pregnancies complicated by preeclampsia," Journal of Maternal-Fetal and Neonatal Medicine, vol. 23, no. 8, pp. 880-886, 2010
39. F. Gotsch, R. Romero, L. Friel et al., "CXCL10/IP-10: a missing link between inflammation and anti-angiogenesis in preeclampsia" Journal of Maternal-Fetal and Neonatal Medicine, vol. 20, no. 11, pp. 777-792, 2007
40. S. Kalkunte, T. Nevers,W. E. Norris, and S. Sharma, "Vascular IL-10: a protective role in preeclampsia," Journal of Reproductive Immunology, vol. 88, no. 2, pp. 165-169, 2011.